A Memphis man was sentenced this week to more than 10 years in federal prison as part of a West Tennessee drug trafficking ...

Novartis' move comes after it abandoned the development of its own Huntington's candidate branaplam last year, which had reached phase 2b development, after concluding that the drug's risks were ...